Investor profile
Oxford Sciences Innovation has backed 11 European tech companies across 12 funding rounds between 2017 and 2021, joining rounds totalling €222M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Pepgen | UK | 1 | €95M |
| Ultromics | UK | 2 | €39M |
| Genomics | UK | 1 | €28M |
| DiffBlue | UK | 1 | €20M |
| Base Genomics | UK | 1 |
| €9.8M |
| Animal Dynamics | UK | 1 | €6.8M |
| Bodle | UK | 1 | €6.8M |
| Orbit Discovery | UK | 1 | €6.5M |
| Metaboards | UK | 1 | €4.0M |
| Oxford VR | UK | 1 | €3.6M |
| BioBeats | Italy | 1 | €2.6M |
| €20M |
| 2017-06 |
| Ultromics | Series A | €11M | 2018-02 |
| Base Genomics | Seed | €9.8M | 2020-03 |
| Animal Dynamics | Series A | €6.8M | 2018-11 |
| Bodle | Other | €6.8M | 2018-01 |
| Orbit Discovery | Other | €6.5M | 2021-07 |
| Metaboards | Other | €4.0M | 2018-02 |
